The NHS Medical Director, Sir Bruce Keogh, has submitted a report regarding cosmetic intervention, the content of which has sparked a media frenzy.
Spurred on by the PIP breast implant scandal in 2011, Sir Keogh and a panel of industry professionals have created a 68-page document in which they have pulled the industry apart in order to rectify, regulate and reconstruct its existing flaws.
With quotes such as: “It is our view that dermal fillers are a crisis waiting to happen” in the report, it is easy to think the cosmetic industry is heading for trouble.
Well, in many ways, it is. It is in trouble because there isn’t always adequate protection or support for the patient and there is a host of unregulated, illegal products being used by people who are simply not qualified to administer it. This then often falls into the laps of the NHS, who are left to pick up the pieces.
The Keogh report proclaims that a person having a non-surgical cosmetic intervention has no more protection and redress than someone buying a ballpoint pen or a toothbrush. That simply has to change. One way is to classify fillers as a prescription-only medical device, a point made by the board.
I cannot tell you how relieved I am of the report’s findings and suggestions as I have encountered far too many unfortunate people who have come to me following botched surgery or unnecessary complications as a result of these so-called ‘Cosmetic Surgery Cowboys’.
We work to an incredibly high standard and ethos at Karidis, whereby our staff are fully qualified to carry out the treatments and where consent forms, cooling off periods, advice on alternative solutions and quality of care are the absolute norm.
With the cosmetic industry in the UK estimated to rise to £3.6 billion by 2015, the government must act quick to make sure the safety standards and common practice guidelines set out in the report are fully implemented to stop more people falling victim to pushy cosmetic sales people, irresponsible advertising, illegal wrinkle smoothing solutions and potentially life-threatening situations.
Only then will we be able to improve the industry as a whole, for both the patient and the professionals.
Follow the link below to read the full report:














